Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term Parasite and host erythrocyte membrane ion gradients refers to the electrochemical potential differences maintained across the plasma membranes of the malaria parasite (Plasmodium falciparum) and its host red blood cell. During its intraerythrocytic development, the parasite actively modifies the host cell's permeability and employs its own transport proteins to maintain a low-sodium, high-potassium internal environment, which is essential for its survival and nutrient uptake (Kirk, 2001). The primary molecular driver of this gradient is the P-type sodium ATPase, PfATP4, which extrudes sodium from the parasite's cytosol (Spillman et al., 2013). Disruption of these gradients by small molecules leads to a rapid influx of sodium ions, causing osmotic swelling and subsequent lysis of the parasite (Rottmann et al., 2010). This physiological system is a major focus for novel antimalarial drug development, with compounds like Cipargamin specifically targeting the proteins responsible for maintaining these gradients (Vaidya et al., 2014). While not a single molecular target, the maintenance of these gradients represents a critical vulnerability in the parasite's life cycle.
Inhibition of the parasite's sodium-extruding ATPase (PfATP4), which collapses the sodium gradient between the parasite and the host erythrocyte, leading to lethal osmotic stress and parasite lysis (Spillman et al., 2013; Rottmann et al., 2010).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parasite and host erythrocyte membrane ion gradients.